D-0255-2022 Class III Terminated
FDA drug recall D-0255-2022 was initiated by UNICHEM PHARMACEUTICALS USA INC on Oct 25, 2021 and is designated Class III. Reason for recall: Discoloration The recall status is terminated (terminated Oct 12, 2022). Affected quantity: 1284 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 1, 2021
- Initiation Date
- Oct 25, 2021
- Termination Date
- Oct 12, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1284 bottles
Product description
Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.
Reason for recall
Discoloration
Distribution pattern
Nationwide within the United States
Code information
Lot #: ZTPM20044, Exp. Date 09/30/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0255-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026